top of page

AGED Diagnostics

We are a team of geneticists and hepatologists who started our pursuits in 2018 when we realized the tools we were using in research were not being well translated into the clinic. We saw an opportunity to apply genomic innovation to improve the lives of patients. Our team is developing the most accurate blood test for liver disease (also known as nonalcoholic steatohepatitis or NASH).

Home (NEW): Welcome

Unmet Medical Needs

icons-04.png

While 1 in 3 Americans or 100 million people have liver disease, many are unaware until the disease has progressed to later stages at which point patient outcomes are poor and healthcare spending can cost up to $1,000,000 per patient. Conversely, early detection of liver disease is not only treatable, but fully reversible.

The bronze standard diagnostic tool is a liver biopsy, which is expensive, invasive, prone to sampling error and bleeding. Imaging tools fail in nearly 60% of patients and there are zero accurate noninvasive tools. 

60%

Home (NEW): Unmet Medical Needs
Home (NEW): What We Do

Our Business

AGED Diagnostics is using genomic innovation to develop the most accurate blood test for liver disease to help physicians keep patients in the monitoring program, reduce the financial burden for health insurers and improve patient outcomes through early detection and intervention.

cover-video.png
Home (NEW): Our Business

What We Do

AGED tools can differentiate benign from advanced liver disease and simultaneously stage fibrosis (liver scarring). Our technology uses a targeted genomic sequencing assessment to measure the concentration of target biomarkers (genetic signatures) in circulation. The presence of biomarkers past a defined concentration indicates a diagnosis of liver disease (NASH) and/or fibrosis.

CORE TECHNOLOGY

icons-01.png

Differentiate Simple Steatosis from NASH

icons-03.png

Identify Advanced Fibrosis

icons-02.png

Exclude Other Chronic Liver Diseases

Our Partners

aged-website-logo-partners-tiles-05.png
aged-website-logo-partners-tiles-03.png
aged-website-logo-partners-tiles-04.png
aged-website-logo-partners-tiles-02.png
aged-website-logo-partners-tiles-01.png
1863_ventures_logo_edited.jpg
Henry Jackson Foundation_edited.jpg
LSA_edited_edited.jpg
download_edited_edited_edited.jpg
Home (NEW): Meet the Team

Meet The Team

Zayas%25252520Headshot%25252520in%25252520Color_edited_edited_edited_edited.jpg
EE Photo_edited.jpg

PhD in Human Genetics

 Expert in genomics research and molecular diagnostics development

Eric Eastman

Acting Chief Operations Officer

Rachel Zayas

Founder & CEO

Geneticist, MBA

 Healthworx (CareFirst) Fellow, Halcyon Fellow

Expert in biomarker development

1649038248864.jpeg

Naim Alkhouri, MD

Clinical Collaborator

Chief Medical Officer, 

Director of the Fatty Liver Program Arizona Liver Health

Coleman Smith_edited_edited_edited_edited.jpg

Coleman Irving Smith, MD

Clinical Collaborator

Transplant Hepatologist

MedStar Georgetown University Hospital

image0 (5)_edited.jpg

Jasmine Kirksey

Director of Laboratory Operations

Bongsoo_edited_edited_edited_edited_edit

Dr. Bongsoo Park

Lead Bioinformaticist

Bioinformatics CRO

Researcher at NIH, Lecturer John Hopkins

Announcements

AGED Blog

Revealing the Hidden Code: The Fascinating Link Between Epigenetics & Liver Disease

Unlocking the Potential: How Spatial Transcriptomics Transforms  Liver Disease Research

Get in Touch

Bethesda, Maryland

Thanks for submitting!

Home (NEW): Contact
bottom of page